nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.347	0.612	CbGbCtD
Palonosetron—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.22	0.389	CbGbCtD
Palonosetron—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0397	0.0917	CcSEcCtD
Palonosetron—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0381	CcSEcCtD
Palonosetron—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0329	CcSEcCtD
Palonosetron—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.0299	CcSEcCtD
Palonosetron—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0294	CcSEcCtD
Palonosetron—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.029	CcSEcCtD
Palonosetron—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0284	CcSEcCtD
Palonosetron—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0232	CcSEcCtD
Palonosetron—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00996	0.023	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00971	0.0224	CcSEcCtD
Palonosetron—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00859	0.0198	CcSEcCtD
Palonosetron—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00832	0.0192	CcSEcCtD
Palonosetron—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00818	0.0189	CcSEcCtD
Palonosetron—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00733	0.0169	CcSEcCtD
Palonosetron—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00685	0.0158	CcSEcCtD
Palonosetron—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.0158	CcSEcCtD
Palonosetron—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.0068	0.0157	CcSEcCtD
Palonosetron—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00642	0.0148	CcSEcCtD
Palonosetron—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.0148	CcSEcCtD
Palonosetron—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00638	0.0147	CcSEcCtD
Palonosetron—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00606	0.014	CcSEcCtD
Palonosetron—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.0136	CcSEcCtD
Palonosetron—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.0135	CcSEcCtD
Palonosetron—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00584	0.0135	CcSEcCtD
Palonosetron—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00581	0.0134	CcSEcCtD
Palonosetron—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.0133	CcSEcCtD
Palonosetron—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.0132	CcSEcCtD
Palonosetron—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.0131	CcSEcCtD
Palonosetron—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00558	0.0129	CcSEcCtD
Palonosetron—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.0128	CcSEcCtD
Palonosetron—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.0121	CcSEcCtD
Palonosetron—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.0113	CcSEcCtD
Palonosetron—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0113	CcSEcCtD
Palonosetron—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.0111	CcSEcCtD
Palonosetron—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.0111	CcSEcCtD
Palonosetron—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.0111	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.011	CcSEcCtD
Palonosetron—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.011	CcSEcCtD
Palonosetron—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.0109	CcSEcCtD
Palonosetron—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00462	0.0107	CcSEcCtD
Palonosetron—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.0106	CcSEcCtD
Palonosetron—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.0105	CcSEcCtD
Palonosetron—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00449	0.0104	CcSEcCtD
Palonosetron—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0102	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00972	CcSEcCtD
Palonosetron—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00965	CcSEcCtD
Palonosetron—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00958	CcSEcCtD
Palonosetron—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00951	CcSEcCtD
Palonosetron—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00948	CcSEcCtD
Palonosetron—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00939	CcSEcCtD
Palonosetron—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00927	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00921	CcSEcCtD
Palonosetron—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00919	CcSEcCtD
Palonosetron—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00395	0.00912	CcSEcCtD
Palonosetron—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00395	0.00912	CcSEcCtD
Palonosetron—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00872	CcSEcCtD
Palonosetron—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00843	CcSEcCtD
Palonosetron—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00843	CcSEcCtD
Palonosetron—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00786	CcSEcCtD
Palonosetron—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00765	CcSEcCtD
Palonosetron—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00754	CcSEcCtD
Palonosetron—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.0073	CcSEcCtD
Palonosetron—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00705	CcSEcCtD
Palonosetron—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00678	CcSEcCtD
Palonosetron—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00672	CcSEcCtD
Palonosetron—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00291	0.00672	CcSEcCtD
Palonosetron—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00668	CcSEcCtD
Palonosetron—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00633	CcSEcCtD
